About Global Antiviral Journal
ISSN (online): 1556-9055
ISSN (print): 1556-9047

Aims and Scope
Global Antiviral Journal publishes peer-reviewed original works related to international efforts to advance antiviral discovery and development, including full-length articles and short papers, as well as solicited review articles, conference reports, letters and book reviews. Occasional supplements contain conference abstracts, presentations and/or posters from international meetings in the field of virology and antiviral research. The scope of the journal encompasses chemistry and biological advances in the fundamental as well as clinical study of antiviral diseases and their treatment. Areas covered include HIV, hepatitis B, hepatitis C and emerging viruses, co-infections, vaccines, animal models, pharmacology, microbicides, alternative therapies, viral dynamics and resistance issues.

The journal is published quarterly online by IHL Press.
All printed supplements are also available online.

Publication Policy
Global Antiviral Journal publishes only original, documented research of high scientific quality, following accepted ethical standards of research. Submission of a manuscript signifies that it has been neither copyrighted, published, nor submitted or accepted for publication elsewhere. 

Editor-in-Chief
Raymond F. Schinazi, Emory University School of Medicine and Veterans Affairs Medical Center, Department of Pediatrics, Medical Research 151H, 1670 Clairmont Road, Decatur, Georgia, 30033, USA

Editorial Office
IHL Press, 26 Bailey Road, Arlington, Massachusetts, 02476, USA
Telephone: +1 781 648 1933
Fax: +1 781 646 2699
info@ihlpress.com

Subscription Details
Subscription prices are available upon request from the Publisher. All inquiries should be directed to the Editorial Office.

Advertising and Supplements
All advertising enquiries and supplement proposals, including advertising within supplements, should be directed to the Editorial Office.